CeNeS Pharmaceuticals PLC (CEN.L) Completes Preparations for Phase III Trial of M6G in US
12/7/2007 8:21:12 AM
More...
|
CeNeS Pharmaceuticals PLC (CEN.L) Release: Annual General Meeting ("AGM") and Extraordinary General Meeting ("EGM") Statement
8/22/2007 10:33:11 AM
More...
|
CeNeS Pharmaceuticals PLC (CEN.L) Licenses New Intravenous Anaesthetic to Ono Pharmaceutical Company, Ltd. in Japan
8/10/2007 11:16:01 AM
More...
|
Major New Review Supports the Broader Potential of CeNeS Pharmaceuticals PLC (CEN.L) COMT Inhibitor Discovery Programme
7/3/2007 1:46:30 PM
More...
|
CeNeS Pharmaceuticals PLC (CEN.L) Release: FDA Approves IND on Lead Product M6G
4/30/2007 11:28:24 AM
More...
|
CeNeS Pharmaceuticals PLC (CEN.L) Files IND for Lead Product M6G
3/28/2007 5:21:29 PM
More...
|
CeNeS Pharmaceuticals PLC (CEN.L): Successful Phase III Results Announced On Lead Product M6G
2/20/2007 10:40:31 AM
More...
|
CeNeS Pharmaceuticals PLC (CEN.L) Release: Placing To Raise £4.82M, Completion Of Recruitment For Phase III Trials Of M6G And Change Of Nominated Adviser
12/4/2006 5:53:58 PM
More...
|
Tripos (TRPS) Extends Its COMT Inhibitor Program With CeNeS Pharmaceuticals PLC (CEN.L)
9/12/2006 11:56:12 AM
More...
|
ErgoMed Signs Co-Development Deal With CeNeS Pharmaceuticals PLC (CEN.L)
7/13/2006 5:02:21 PM
More...
|
|